X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (93) 93
clsi (81) 81
humans (71) 71
microbiology (58) 58
infectious diseases (50) 50
eucast (41) 41
microbial sensitivity tests - methods (33) 33
resistance (33) 33
antifungal agents - pharmacology (32) 32
anti-bacterial agents - pharmacology (25) 25
microbial sensitivity tests (25) 25
mycology (25) 25
fluconazole (21) 21
pharmacology & pharmacy (21) 21
amphotericin-b (19) 19
medical laboratory technology (19) 19
voriconazole (19) 19
drug resistance (18) 18
epidemiology (18) 18
infectious disease (18) 18
antifungal agents (17) 17
candida (17) 17
susceptibility (17) 17
internal medicine (16) 16
mic (16) 16
microbial sensitivity tests - standards (16) 16
antifungal susceptibility (15) 15
infections (15) 15
bacteria (14) 14
candida - drug effects (14) 14
epidemiologic cutoff values (14) 14
female (14) 14
itraconazole (14) 14
male (14) 14
amphotericin b (13) 13
analysis (13) 13
bacterial infections and mycoses (13) 13
laboratories (13) 13
antifungal susceptibility testing (12) 12
article (11) 11
breakpoints (11) 11
escherichia coli - drug effects (11) 11
health aspects (11) 11
medicine (11) 11
medicine & public health (11) 11
methods (11) 11
reference values (11) 11
reproducibility of results (11) 11
surveillance (11) 11
aged (10) 10
agents (10) 10
antimicrobial agents (10) 10
broth microdilution (10) 10
drug resistance, fungal (10) 10
middle aged (10) 10
minimum inhibitory concentration (10) 10
amphotericin b - pharmacology (9) 9
antibiotics (9) 9
antimicrobial resistance (9) 9
aspergillus (9) 9
candida spp (9) 9
caspofungin (9) 9
child (9) 9
dermatology (9) 9
management (9) 9
medical laboratories (9) 9
micafungin (9) 9
mortality (9) 9
mycoses (9) 9
reference intervals (9) 9
triazoles - pharmacology (9) 9
adolescent (8) 8
adult (8) 8
animals (8) 8
antifungal agents - therapeutic use (8) 8
antimicrobial susceptibility testing (8) 8
candida - isolation & purification (8) 8
clsi broth microdilution (8) 8
echinocandins (8) 8
echinocandins - pharmacology (8) 8
etest (8) 8
fluconazole - pharmacology (8) 8
fungi (8) 8
posaconazole (8) 8
quality control (8) 8
reference standards (8) 8
young adult (8) 8
antiparasitic agents (7) 7
azole resistance (7) 7
biochemical phenomena, metabolism, and nutrition (7) 7
biology (7) 7
chemistry (7) 7
child, preschool (7) 7
clinical and laboratory standards institute (7) 7
disk diffusion (7) 7
enterobacteriaceae (7) 7
fungal infections (7) 7
guidelines (7) 7
hospitals (7) 7
infection (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 04/2018, Volume 90, Issue 4, pp. 324 - 328
Meropenem–vaborbactam is a carbapenem/cyclic boronic acid β-lactamase inhibitor combination primarily active against Gram-negative bacilli, including those... 
RPX7009 | CLSI M23 | VABOMERE | Quality control | Meropenem–vaborbactam | INFECTIOUS DISEASES | HEALTHY ADULT SUBJECTS | CARBAPENEMASES | MICROBIOLOGY | Meropenem-vaborbactam | VABOMERE (TM) | ENTEROBACTERIACEAE
Journal Article
Laboratory Medicine, ISSN 0007-5027, 03/2013, Volume 44, Issue 2, pp. e37 - e43
Objective: To verify the upper reference limit and define the population-based reference interval (RI) for thyroid peroxidase antibody, according to Clinical... 
CLSI | Thyroid peroxidase antibody | Reference interval | MEDICAL LABORATORY TECHNOLOGY | thyroid peroxidase antibody | reference interval
Journal Article
Journal Article
Journal of Diabetes Science and Technology, ISSN 1932-2968, 11/2017, Volume 11, Issue 6, pp. 1240 - 1246
Recently, the Food and Drug Administration (FDA) published guidance documents for point-of-care testing (POCT) and over-the-counter (OTC) blood glucose... 
blood glucose monitoring system | FDA guidance | CLSI guideline | SMBG | POCT | ISO 15197
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2017, Volume 61, Issue 8
Candida species were tested for susceptibility to caspofungin, anidula-fungin, and micafungin in order to evaluate the roles of Etest and Sensititre YeastOne... 
Echinocandins | Sensititre YeastOne | Antifungal susceptibility testing | Candida species | Etest | CLSI | CASPOFUNGIN | GLABRATA | MICAFUNGIN | MANAGEMENT | ANIDULAFUNGIN | MICROBIOLOGY | antifungal susceptibility testing | GUIDELINE | echinocandins | RESISTANCE | PHARMACOLOGY & PHARMACY | FKS MUTATIONS | IN-VITRO ACTIVITY
Journal Article
Journal Article
Journal of Medical Microbiology, ISSN 0022-2615, 02/2017, Volume 66, Issue 2, pp. 213 - 216
The antifungal susceptibilities of 598 isolates of Candida spp. (bloodstream and other sterile sites) to liposomal amphotericin B (L-AmB) versus amphotericin B... 
CLSI broth microdilution | Amphotericin B deoxycholate | Liposomal amphotericin B | E-test | Candida | liposomal amphotericin B | MANAGEMENT | amphotericin B deoxycholate | MICROBIOLOGY | AGENTS | NEPHROTOXICITY | GUIDELINE
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2018, Volume 62, Issue 1
Journal Article
Current Topics in Medicinal Chemistry, ISSN 1568-0266, 2018, Volume 18, Issue 9, pp. 779 - 786
Journal Article